COST IMPLICATIONS OF WASTAGE OF DRUGS - FOCUS ON INSULIN

被引：11

作者：

COSTA, B ^{[1
]}

BELMONTE, M ^{[1
]}

机构：

[1] PRIMARY HLTH CARE,DIABET STUDY GRP,TARRAGONA,SPAIN

来源：

关键词：

D O I：

10.2165/00019053-199406010-00001

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

[No abstract available]

引用

页码：1 / 4

页数：4

共 18 条

[1] Bloom B.S., Knorr R.S., Evans A.E., The epidemiology of disease expenses, JAMA, 253, (1985)
[2] Dean M., Curbing the drugs bill, Lancet, 340, (1992)
[3] Laporte J.R., Amau J.M., El decreto de financiación selectiva de medicamentos a cargo de la seguridad social, Med Clin, 101, (1993)
[4] Laporte J.R., Porta M., Capell D., Drug utilization studies: a tool for determining the effectiveness of drug use, Brit J Clin Pharmacol, 16, (1983)
[5] Bergman U., Sjqvist F., Measurement of drug utilization in Sweden: Methodological and clinical implications, Acta Med Sand, pp. 15-20, (1984)
[6] Evans L., The problem of non—compliance with drug therapy, Drugs, 25, pp. 63-76, (1983)
[7] Begg D., Do patients cash prescriptions, JR Coll Gen Pract, 34, (1984)
[8] Pearson R.M., Who is taking their tablets, BMJ, 285, (1982)
[9] Stika L., Patterns in drug utilization, Acta Med Sand, (1984)
[10] Costa B., Hernandez J.M., Consumo de medicación en la diabetics mellitus (III), Med Clin, 100, (1993)